20342 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole; Oxazoles condensed with carbocyclic rings
Spirocyclic CETP inhibitors
#602Toxic aldehyde related diseases and treatment
#603Substituted 7-azabicycles and their use as orexin receptor modulators
#604HETEROCYCLIC COMPOUNDS AND USES THEREOF
#605METHOD FOR TREATING OBESITY
#606Substituted pyrido[2,3-g]quinazolines as dopamine Dreceptor agonists
#607Compounds that inhibit human DNA ligases and methods of treating cancer
#608Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
#609Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#610Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
#611Amine derivative or salt thereof
#612Spirohydantoin compounds and their use as selective androgen receptor modulators
#613Calcium flux agonists and methods thereof
#614MEDICAMENT-CONTAINING HOLLOW PARTICLE
#615Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
#616Hematopoietic growth factor mimetic small molecule compounds and their uses
#617INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#618Pharmaceutical composition for the treatment of Duchenne muscular dystrophy
#619SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#620Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B
#621Compounds and methods for treating mammalian gastrointestinal microbial infections
#622Compositions and methods of treating retinal disease
#623Compositions and methods of treating retinal disease
#624Anticancer supplement agent including benzo[D]oxazol derivative as effective ingredient
#625Inhibitors of CRL4 ubiquitin ligase and uses thereof
#626Therapeutic agent for dyslipidemia
#627CANCER CELL INHIBITORY DRUG AND CANCER STEM-CELL DETECTION PROBE
#6283-O-heteroaryl-ingenol
#629Methods for treating Parkinson's disease
#630Compounds that enhance Atoh1 expression
#631BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#632IRE-1α inhibitors
#633Method of treating . infection
#634Glucagon antagonists
#635TRANSTHYRETIN LIGANDS CAPABLE OF INHIBITING RETINOL-DEPENDENT RBP4-TTR INTERACTION FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION, STARGARDT DISEASE, AND OTHER RETINAL DISEASE CHARACTERIZED BY EXCESSIVE LIPOFUSCIN ACCUMULATION
#636Combination of kinase inhibitors and uses thereof
#637METHODS OF USING ESTROGEN RECEPTOR-BETA LIGANDS AS RADIATION MITIGATORS
#638Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#639METHOD FOR TREATING OBESITY
#640Therapeutic approaches for treating Alzheimer's disease
#641Pyrazolopyrrolidine derivatives and their use in the treatment of disease
#642Compositions and methods for increasing insulin sensitivity
#643Methods for administering weight loss medications
#644Modulation of Tissue Transglutaminase Activation in Disease
#645Dihydropyrazoles
#646Compounds for modulating TLR2
#647Therapy for transthyretin-associated amyloidosis
#648Spectinamides as anti-tuberculosis agents
#649Bicyclic compound
#650Heterocyclic derivative and pharmaceutical drug
#651Factor IXa inhibitors
#652Selective glycosidase inhibitors and uses thereof
#653MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#654Antiviral agents
#655Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
#656Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#657Mycobacterial Disease Detection, Treatment, and Drug Discovery
#658Compounds that inhibit human DNA ligases and methods of treating cancer
#659Compounds and methods for inducing chondrogenesis
#660Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors
#661Inhibitors of the plasmodial surface anion channel as antimalarials
#662METHODS FOR PROPHYLATIC APPETITE SUPPRESSION
#663SEROTONIN RECEPTOR MODULATOR
#664Compositions for treating neurological disorders
#665Tricyclic compound and pharmaceutical use thereof
#666DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#667Oxidosqualene cyclase as a protein target for anticancer therapeutics
#668COMPOUNDS AND METHODS FOR TARGETING LEUKEMIC STEM CELLS
#669PDE-10 INHIBITORS
#670Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
#671Complement pathway modulators and uses thereof
#672Methods of treating cancer comprising targeting NQO1
#673Small molecule inhibitors of USP1 deubiquitinating enzyme activity
#674COMBINATIONS AND METHODS FOR TREATING NON AGE-RELATED HEARING IMPAIRMENT IN A SUBJECT
#675Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
#676Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
#677Hepatitis C virus inhibitors
#678Treatment of Microbial Infections
#679Dihydropyrazoles
#680FORMULATION AND DOSING OF HSP90 INHIBITORY COMPOUNDS
#681Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
#682Methods and compositions related to dopaminergic neuronal cells
#683Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#684High-throughput methods for determining pharmacological levels of plasma D-serine
#685IRE-1α inhibitors
#686ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#687Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#688REVERSED BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS
#689Antibacterial agents
#690Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
#691Heterocyclic compounds and uses thereof
#692Glucagon antagonists
#693Antiviral agents
#694Reporter system for high throughput screening of compounds and uses thereof
#695Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
#696Compounds that enhance Atoh1 expression
#697Compositions and methods for the treatment of macular degeneration
#698Hematopoietic growth factor mimetic small molecule compounds and their uses
#699Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
#700METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS
#701Therapeutic approaches for treating alzheimer'S disease
#702BRCA1-based breast or ovarian cancer treatment agents and methods of use
#703Oxadiazole derivative having endothelial lipase inhibitory activity
#704FXR (NR1H4) binding and activity modulating compounds
#705SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#706Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#707AGENT FOR REDUCING VISCERAL FAT WEIGHT
#7081,2-bis-sulfonamide derivatives as chemokine receptor modulators
#709ANTIBACTERIAL AGENTS
#710Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
#711BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS
#712Layered pharmaceutical formulations
#713Inhibitors of hepatitis C virus replication
#714Benzoxazolone derivatives as aldosterone synthase inhibitors
#715Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
#716HSP90 Inhibitors for Treating Non-Small Cell Lung Cancer in Wild-Type EGFR and/or KRAS Patients
#717DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS
#718Drug containing benzophenone derivative or its salt
#719COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF
#720Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#721Methods and compositions for treating anxiety
#722NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#723Method for treating a B-raf associated cancer with an Hsp90 inhibitor
#724Tricyclic carbamate JAK inhibitors
#725Compositions and methods of treating retinal disease
#726Acetic acid amide derivative having inhibitory activity on endothelial lipase
#727BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#728Selective glycosidase inhibitors and uses thereof
#729Antiviral agents
#730Antimicrobial compounds
#731CC-1065 analogs and their conjugates
#732Serotonin receptor modulators
#733Tricyclic compound and pharmaceutical use thereof
#734NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
#735Drug combinations for the treatment of duchenne muscular dystrophy
#736Tricyclic compound and pharmaceutical use thereof
#737METHODS FOR TREATING CNS DISORDERS
#738PDE-10 inhibitors
#739Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
#740Compounds for modulating TLR2
#741Inhibitors of the plasmodial surface anion channel as antimalarials
#742Stat modulators
#7432-oxothiazole compounds and method of using same for chronic inflammatory disorders
#744Spectinamides as anti-tuberculosis agents
#745METHOD FOR TREATING OBESITY
#746IH CHANNEL INHIBITORS FOR THE PROMOTION OF WAKEFULNESS
#747Small Molecule Inhibitors of Botulinum Neurotoxins
#748Antimicrobial compounds
#749Use of thioflavin-like compounds to increase life span and/or health span
#750METHODS OF USE OF ANTIVIRAL COMPOUNDS
#751Methods for administering weight loss medications
#752Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
#753NPY Y5 ANTAGONIST
#754COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS
#755USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF ALPHA INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
#756Hepatitis C virus inhibitors
#757Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent
#758COMPOUNDS FOR TREATING MUSCULAR DYSTROPHY
#759MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
#760NPY Y5 antagonist
#761AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY
#762DRUG CONTAINING BENZOPHENONE DERIVATIVE OR ITS SALT
#763Composition for regenerative treatment of cartilage disease
#764New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
#765Linked dibenzimidazole derivatives
#766COMPOSITIONS OF AN ANTICONVULSANT AND MIRTAZAPINE TO PREVENT WEIGHT GAIN
#767Antibacterial agents
#768Substituted pyrimidyl guanidine derivatives having anticancer activity
#769ESTER COMPOUND AND MEDICAL USE THEREOF
#770S-Nitrosothiol Compounds and Related Derivatives
#771Compounds that inhibit human DNA ligases and methods of treating cancer
#772Triazole compounds that modulate HSP90 activity
#773Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#774Method for the treatment of metabolic disorder containing benzazole derivatives as an active ingredient
#775Prophylactic and/or therapeutic agent for hyperlipidemia
#776METHODS FOR TREATING CNS DISORDERS
#777Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
#778Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
#779Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#780Antimicrobial compounds and methods of use thereof
#781DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES
#782Sulfonamide compound or salt thereof
#783Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
#784Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
#785PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROGENIC PAIN
#786Benzoxazoles Useful in the Treatment of Inflammation
#787Delivery of antipsychotics through an inhalation route
#788PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#789Compounds that enhance Atoh1 expression
#790Tricyclic compound and pharmaceutical use thereof
#791Compositions and methods of treating retinal disease
#792BRCA1-BASED BREAST OR OVARIAN CANCER PREVENTION AGENTS AND METHODS OF USE
#793Oral composition comprising 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or salt thereof
#794Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
#795PHENYLAMINO-BENZOXAZOLE SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THEIR PRODUCTION AND USE THEREOF AS MEDICAMENTS
#796FUNCTIONALIZED, SOLID POLYMER NANOPARTICLES COMPRISING EPOTHILONES
#797Treatment for Cardiovascular Disease
#798Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#799SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#800TUMOR SUPPRESSOR
#801METHODS FOR TREATING MACULAR EDEMA AND OCULAR ANGIOGENESIS USING AN ANTI-INFLAMMATORY AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR
#802METHOD FOR TREATING OBESITY
#803Treatment of Duchenne muscular dystrophy
#804C-glycoside derivatives and salts thereof
#805Mycobacterial disease detection, treatment, and drug discovery
#806Antiviral agents
#807COMPOSITIONS OF AN ANTICONVULSANT AND AN ANTIPSYCHOTIC DRUG AND METHODS OF USING THE SAME FOR AFFECTING WEIGHT LOSS
#808PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
#809Method for treating obesity
#810Transdermal Preparation for External Use Containing Antiinflammatory/Analgesic Agent
#811Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#812PRIMARY N-HYDROXYLAMINES
#813COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERS
#814PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#815Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
#816LTA4H modulators and uses thereof
#817Organic compounds
#818Extracts of Ginkgo Biloba
#819NOVEL METHODS USING ZONISAMIDE
#820METHOD FOR TREATING OBESITY
#821USE OF ER-BETA SELECTIVE LIGANDS FOR TREATING ACUTE LUNG INJURIES
#822PHARMACEUTICAL FORMULATIONS OF A CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#823PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#824Delivery of drug esters through an inhalation route
#825Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds
#826METHODS FOR PREVENTING INFLAMMATION DURING SURGERY
#827BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS
#828Layered pharmaceutical formulations
#829METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS
#830Combination Therapy
#831Composition for accelerating bone fracture healing
#832Method for treating proliferative disorders with HSP90 inhibitors
#833Combination of Gaboxadol and 5Ht2 Antagonists
#834Inhibitors of Aquaporin 4, methods and uses thereof
#835Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
#836Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease
#837Stable emulsion formulations
#838Treatment for Cardiovascular Disease
#839Aryl aniline βadrenergic receptor agonists
#840PHARMACEUTICAL FORMULATIONS OF AN ANHYDROUS CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#841PHARMACEUTICAL FORMULATIONS OF A MONOHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#842Liquid and Semi-Solid Pharmaceutical Formulations and Processes
#843Medicament Combinations for the Treatment of Respiratory Diseases
#844Benzisoxazoles
#845Novel heterocyclic compound
#846Aqueous Pharmaceutical Formulations of ER-beta Selective Ligands
#847COMPOSITIONS OF AN ANTICONVULSANT AND METHODS OF USING THE SAME FOR REVERSING WEIGHT GAIN
#848Delivery of opioids through an inhalation route
#849C-glycoside derivatives and salts thereof
#850Composition for regenerative treatment of cartilage disease
#851Antiviral agents
#852Antiviral agents
#853SUSTAINED-RELEASE FORMULATION OF ZONISAMIDE
#854Combination of an H3 antagonist/inverse agonist and an appetite suppressant
#855Compositions and methods of treating retinal disease
#856Compositions and methods for reducing food cravings
#857Compositions and methods for increasing insulin sensitivity
#858Small molecule inhibitors of botulinum neurotoxins
#859Broad spectrum antibacterial compounds
#860Antifungal agent containing heterocyclic compound
#861Formulation comprising a drug of low water solubility and method of use thereof
#862Composition and synthesis of new reagents for inhibition of HIV replication
#863Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
#864Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
#865Inhibitors for extracellular signal-regulated kinase docking domains and uses therefor
#866BENZOXAZOLE DERIVATIVE OR ANALOGUE THEREOF FOR INHIBITING 5-LIPOXYGENASE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#867Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#868Carbostyril derivatives and mood stabilizers for treating mood disorders
#869Activator of peroxisome proliferator-activated receptor δ
#870PREVENTION AND TREATMENT OF HEARING DISORDERS
#871NPY Y5 antagonist
#872Delivery of muscle relaxants through an inhalation route
#873Delivery of antihistamines through an inhalation route
#874Delivery of sedative-hypnotics through an inhalation route
#875Delivery of antipsychotics through an inhalation route
#876METHODS AND COMPOSITIONS FOR MANAGING PSYCHOTIC DISORDERS
#877Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
#878Delivery of drug esters through an inhalation route
#879Delivery of erectile dysfunction drugs through an inhalation route
#880Delivery of analgesics through an inhalation route
#881Delivery of physiologically active compounds through an inhalation route
#882Delivery of diphenhydramine through an inhalation route
#883Delivery of anti-migraine compounds through an inhalation route
#884Delivery of antidepressants through an inhalation route
#885Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
#886Compounds for use in weight loss and appetite suppression in humans
#887Delivery of compounds for the treatment of Parkinson's through an inhalation route
#888Delivery of beta-blockers through an inhalation route
#889Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis
#890Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
#891Stable pharmaceutical formulations of zonisamide and methods for their manufacture
#892Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
#893Delivery of antiemetics through an inhalation route
#894Compounds for use in weight loss and appetite suppression in humans
#895Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
#896Delivery of stimulants through an inhalation route
#897Compounds for use in weight loss and appetite suppression in humans
#898Novel uses for estrogen beta agonists
#899Heteroaromatic pentacyclic compound and medicinal use thereof
#900Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury